Morgan Curtis

Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia

Yi‐Bin Chen, Shuli Li, Andrew A. Lane et al. · Biology of Blood and Marrow Transplantation · 2014 · 234 citations · Full text

Medicine, Hematology, Oncology +16

Phase 2 trial of high‐dose rituximab with high‐dose cytarabine mobilization therapy and high‐dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non‐Hodgkin lymphoma

Yi‐Bin Chen, Tracy T. Batchelor, Shuli Li et al. · Cancer · 2014 · 73 citations · Full text

Medicine, Immunology, Pharmacotherapy +15

SAT0193 Results of a randomized placebo controlled phase ia study of AGS-009, a humanized anti-interferon-α monoclonal antibody in subjects with systemic lupus erythematosus

Irina Y. Tcherepanova, Morgan Curtis, Michèle M. Sale et al. · Annals of the Rheumatic Diseases · 2012 · 34 citations

Life Sciences, Immunology, Pharmacology +16

Pazopanib and lapatinib in patients with relapsed malignant glioma: Results of a phase I/II study

Sophia Frentzas, Morris D. Groves, Jorge Barriuso et al. · Journal of Clinical Oncology · 2009 · 11 citations

Medicine, Oncology, Pharmacology +16